Provided by Tiger Fintech (Singapore) Pte. Ltd.

VistaGen Therapeutics

2.16
+0.01000.47%
Post-market: 2.160.00000.00%19:59 EDT
Volume:78.64K
Turnover:169.34K
Market Cap:62.34M
PE:-1.40
High:2.22
Open:2.20
Low:2.10
Close:2.15
Loading ...
Aug 11, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 11, 2022

Major Issues Report

8-K - Current report
Jul 22, 2022

Major Issues Report

8-K - Current report
Jul 08, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jun 23, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jun 23, 2022

Major Issues Report

8-K - Current report
Jun 22, 2022

Major Issues Report

8-K - Current report
Jun 09, 2022

Major Issues Report

8-K - Current report
May 06, 2022

Major Issues Report

8-K - Current report
May 03, 2022

Major Issues Report

8-K - Current report
Apr 22, 2022

Major Issues Report

8-K - Current report
Apr 14, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Apr 13, 2022

Major Issues Report

8-K - Current report
Feb 15, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 10, 2022

Major Issues Report

8-K - Current report
Feb 04, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 10, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]